The Quantellect read.As of Nov 19, 2026, 4 active firms cover Cabot Corporation: 1 rate it Buy or better, 2 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $78.00 to $98.00, so the covering firms are broadly aligned. The average target of $88.00 sits 19% above the current $73.98. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.61 next quarter toward $7.42 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Neutral
Strong Buy00%
Buy125%
Neutral250%
Sell125%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$88.00
+19.0% upside
Average target across 4 active firms as of Nov 19, 2026 vs $73.98 current
Highest Target$98.00
Average Target$88.00
Lowest Target$78.00
Detailed analyst forecasts for CBT
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 1 of 4 active firms rate CBT a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CBT EPS & revenue forecast
EPS · NEXT QUARTER
$1.61
Range $1.39 – $1.71 · 4 analysts · +0% YoY
Next period, 4 analysts expect Cabot Corporation to earn $1.61 a share (range $1.39 – $1.71), versus $1.61 a year earlier. Full-year consensus is $6.56, growing to $7.42 the year after.
REVENUE · NEXT QUARTER
$928.2M
Range $894.0M – $948.0M · 4 analysts · +3% YoY
Revenue is expected to reach $928.2M (range $894.0M – $948.0M), +2.7% year-over-year. Full-year consensus is $3.9B, rising to $4.0B next year.
Top analysts covering Cabot Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CBT.
#1
Joshua Spector
UBS · Rank #56
Neutral
$86.00+16.2% to target
Overall win rate
50%
+ Follow
#2
Jeffrey Zekauskas
JP Morgan · Rank #114
Sell
$78.00+5.4% to target
Overall win rate
51%
+ Follow
#3
John Roberts
Mizuho · Rank #125
Neutral
$90.00+21.7% to target
Overall win rate
48%
+ Follow
#4
DB
David Begleiter
Deutsche Bank · Rank #447
Neutral
$80.00+8.1% to target
Overall win rate
29%
+ Follow
#5
PO
Pete Osterland
Truist Financial
Buy
No targeton CBT
Coverage
—
+ Follow
CBT stock forecast FAQ
What is CBT's average 12-month price target?+
The 4 active firms with a live target average $88.00 for Cabot Corporation over the next 12 months, ranging from a $98.00 high to a $78.00 low, as of Nov 19, 2026.
Is CBT stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 4 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 2 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CBT?+
The Street-high target is $98.00 (Truist Securities), and the Street-low is $78.00 (JP Morgan). The average of all 4 active-firm targets is $88.00.
How many active Wall Street firms cover CBT?+
4 active firms have a recognized rating on Cabot Corporation as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CBT?+
Among analysts who currently cover CBT, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #56). Their current call is Neutral with a $86.00 target.
What is Cabot Corporation's projected EPS for next quarter?+
The consensus estimate is $1.61 per share (range $1.39 – $1.71) across 4 analysts. Full-year EPS is projected at $6.56, rising to $7.42 the following year.
How much revenue is Cabot Corporation expected to report next quarter?+
Consensus revenue is $928.2M (range $894.0M – $948.0M). Full-year revenue is projected at $3.9B, growing to $4.0B next year.
Have analysts been upgrading or downgrading CBT lately?+
As of Nov 19, 2026, 1 of 4 active firms rate CBT a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CBT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.